Canaccord Genuity Group Trims Akero Therapeutics (NASDAQ:AKRO) Target Price to $56.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Akero Therapeutics (NASDAQ:AKRO – Free Report) in a research note released on Monday morning, Benzinga reports. They currently have a $50.00 price objective on the stock. HC Wainwright also issued estimates for Akero Therapeutics’ Q2 2024 earnings at ($0.82) EPS, Q3 2024 earnings at ($0.87) EPS, […]
Akero Therapeutics (NASDAQ:AKRO) Coverage Initiated at Bank of America theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report)’s stock price was up 13.1% during mid-day trading on Tuesday . The stock traded as high as $27.16 and last traded at $27.04. Approximately 605,894 shares were traded during trading, a decline of 37% from the average daily volume of 956,964 shares. The stock had previously closed […]
Akero Therapeutics (NASDAQ:AKRO – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.71) earnings per share for the quarter, missing the consensus estimate of ($0.70) by ($0.01), MarketWatch Earnings reports. Akero Therapeutics Stock Performance AKRO stock opened at $14.91 on Wednesday. The firm has a market cap of $829.00 million, […]